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signiﬁcant stenosis at infrainguinal bypass
anastomoses
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Jan Albert Vos, MD, PhD,c Evert P. A. Vonken, MD, PhD,d Frans L. Moll, MD, PhD,a and
Gert Jan de Borst, MD, PhD,a Utrecht and Nieuwegein, The Netherlands
Objective: The durability of an infrainguinal bypass may be hampered by development of stenosis at the anastomoses.
We describe the patency of percutaneous transluminal angioplasty (PTA) of these anastomotic stenoses.
Methods: Any venous or prosthetic infrainguinal bypass with a hemodynamically signiﬁcant anastomotic stenosis,
symptomatic or asymptomatic, was considered a bypass at risk (BAR) for occlusion. All BARs undergoing PTA
in two large vascular referral centers between January 2005 and December 2010 were retrospectively reviewed. Proce-
dural success was deﬁned as <30% residual stenosis. Primary end points were primary, assisted primary, and secondary
patency rates.
Results: Included were 43 patients with 43 BARs (31 venous, 11 prosthetic, and 1 unknown conduit; 19 supragenicular
and 24 infragenicular). Mean follow-up was 17 months (range, 0-57 months). Procedures constituted 48 interventions
for proximal (n [ 13), distal (n [ 25), or combined (n [ 5) anastomotic stenoses. Procedural success was 96%. The
primary, assisted primary, and secondary patency rates were 58%, 85%, and 88%, respectively, at 2 years.
Conclusions: PTA for infrainguinal BAR due to anastomotic stenosis is technically feasible with acceptable
durability. PTA for these anastomotic stenoses may be considered a safe option as the ﬁrst-line treatment. (J Vasc Surg
2014;60:696-701.)In the endovascular era, infrainguinal bypass surgery
still has a place, especially for long-segment occlusions or
after failed endovascular interventions.1,2 The autologous
saphenous vein graft has been shown to be the conduit
of choice, but long-term patency is still threatened by he-
modynamically signiﬁcant in-graft or anastomotic stenoses,
making the bypass at risk (BAR) for occlusion.3 Graft
surveillance remains controversial, however, although at-
tempts have been made to develop an algorithm to stream-
line surveillance of infrainguinal bypass grafts.4,5
The optimal treatment for a BAR due to anastomotic
stenosis has not clearly been elucidated, and the data
focusing on patency of interventions for infrainguinal
BAR are limited.1,6 Furthermore, most of these studies
are heterogeneous for the type of BAR and the location
of the stenosis, whether in-graft or anastomotic. Data on
the selective treatment of anastomotic stenoses in infrain-
guinal bypass grafts are scarce.6,7 The aim of this studythe Department of Surgery, University Medical Center Utrecht,
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://dx.doi.org/10.1016/j.jvs.2014.03.289was to assess the results of selective percutaneous translu-
minal angioplasty (PTA) of restenosis at the anastomosis
in infrainguinal BAR.METHODS
Data collection. Data were retrospectively obtained
from two vascular referral centers in the Netherlands
(St. Antonius Hospital, Nieuwegein, and University Medi-
cal Centre, Utrecht) and were assessed on an intention-to-
treat principle. The Institutional Review Board of both
centers ethically approved this retrospective case cohort
study and issued a waiver for patient informed consent.
Patients undergoing revascularization of anastomotic
stenoses in a primary implanted venous or prosthetic
infrainguinal bypass were retrospectively identiﬁed by a re-
view of all performed endovascular interventions in infrain-
guinal bypasses within the time frame January 2005 to
December 2010. Retrieved data included patient and
bypass parameters, lesion and treatment characteristics,
duration of follow-up, and subsequent interventions at
anastomotic sites during further follow-up.
Follow-up started at the moment of endovascular treat-
ment of the BAR and ended at the last medical follow-up at
the outpatient clinic with a check on patency of the bypass
or at the time of patency loss conﬁrmed by imaging.
Patients under follow-up surveillance within our own cen-
ters were kept to a strict follow-up schedule and were always
included. No patients in this subset were lost to follow-up.
Infrainguinal bypasses with anastomotic stenoses
that underwent PTA at the proximal, distal, or both
Table I. Patient characteristics
Variable
Mean 6 SD or No. (%)
(N ¼ 43)
Age, years 68 6 10
Female 11 (26)
Diabetes mellitus 15 (35)
Hypertension 23 (54)
Hypercholesterolemia 22 (52)
Smoking $10 pack-years 19 (44)
Coronary artery disease 12 (28)
SD, Standard deviation.
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Exclusion criteria were interventions for a stenosis directly
after thrombolysis for an acutely occluded bypass, previous
interventions for a nonanastomotic in-graft stenosis, treat-
ment of nonanastomotic in-graft stenosis during follow-up
after initial treatment (a concomitantly treated in-graft
lesion was not an exclusion criterion), a bypass implanted
for a popliteal aneurysm (due to different etiology), and
absence of procedural data regarding bypass or follow-up,
or both.
Patient identiﬁcation and treatment. Patients pre-
sented with symptomatic or asymptomatic stenosis as
detected by follow-up duplex ultrasound scanning
(DUS). Intervention for stenosis in BAR was considered
for DUS-determined >70% stenosis, with peak systolic
velocity (PSV) <45 cm/s or >300 cm/s, or when the
velocity ratio (PSVstenosis/PSVproximal) was >4.0.
3,8-10 In
addition to DUS, supplemental imaging with magnetic
resonance angiography or computed tomography angiog-
raphy was performed in most patients to conﬁrm DUS
ﬁndings and report the inﬂow and outﬂow in more detail
to prepare for the optimal treatment strategy. A multidis-
ciplinary panel of interventional radiologists and vascular
surgeons decided on the appropriateness of intervention
and type of treatment.
During follow-up after PTA, patients were prescribed
their preoperative regimen or began antiplatelet therapy.
Patients postoperatively used antiplatelet medication
(aspirin, n ¼ 18; clopidogrel and aspirin, n ¼ 4; dipyrida-
mole, n ¼ 1), a vitamin K antagonist (acenocoumarol,
n ¼ 13; phenprocoumon, n ¼ 4), or a combination of
those (n ¼ 3). Lipid-lowering medication (eg, statin) was
prescribed in case of hyperlipidemia (n ¼ 22), unless
contraindicated.
In the two participating vascular centers, the ﬁrst-line
treatment for hemodynamically signiﬁcant anastomotic ste-
noseswas PTA,with orwithout stent placement. Retrograde
contralateral common femoral artery puncture was the
preferred technique, with use of a supporting 6F guiding
sheath. Before the superﬁcial femoral artery lesion was
crossed, heparin (5000 IU) was administered. The lesion
was crossed with a 0.035-inch or 0.018-inch guidewire,
overwhich a standard PTAballoonwas advanced. The diam-
eter of the balloon was similar to the diameter of the native
vessel (range, 4-7mm) andwas inﬂated to nominal pressure.
If the origin of the profunda femoral artery (PFA) was
deemed at risk for complications from PTA of the bypass
origin, a second guidewire was placed in the PFA before
the angioplasty was performed. This provided the opportu-
nity to perform a PTA of the bypass and still retain access to
the PFA. If the PFA inadvertently became occluded by the
PTA of the bypass, it could be reaccessed using this wire.
Stent placement was performed in case of a suboptimal
interventional effect. The latter was deﬁned as >30% resid-
ual stenosis or a ﬂow-limiting dissection after PTA. In all
stent cases, a self-expandable nitinol stent was used, with
a diameter oversized by 1 mm in reference to the diameter
of the native vessel.Postprocedural success was assessed with angiography
in all patients and deﬁned as <30% residual stenosis. In
case of >30% residual stenosis or occlusion <30 days, the
intervention was considered unsuccessful. Primary surgery
was performed after initially failed PTA or when surgery
was already scheduled or performed for a concomitant
problem (mostly for inﬂow problems of the bypass).
Study end points and deﬁnitions. Primary study end
points, according to the criteria established by the Society
for Vascular Surgery, were used to assess freedom from oc-
clusion in BARs.11 Primary patency was deﬁned as freedom
from reintervention needed to maintain patency of the
bypass due to anastomotic stenosis or occlusion. Assisted
primary patency allows repeat intervention to prevent a
bypass from occlusion, and secondary patency assesses
bypass patency regardless of needed intervention(s) to
resolve occlusion of the bypass.
Statistical analysis. Kaplan-Meier survival analysis was
used for survival analysis. Differences were considered sta-
tistically signiﬁcant when the P value was <.05. Outcomes
were compared using log-rank testing. Patients with
follow-up of <24 months or who died during follow-up
were censored in the analysis.
RESULTS
Patient selection. A total of 178 patients undergoing
endovascular intervention for in-graft stenoses in 193 by-
passes were reviewed, of which 111 patients were further
reviewed due to anastomotic stenoses in primary implanted
bypasses. Exclusions of the latter group were due to
intervention for stenoses directly after thrombolysis for an
acutely occluded bypass (n ¼ 8), treatment(s) of previous
nonanastomotic in-graft stenosis (n ¼ 4), nonanastomotic
in-graft stenosis during follow-up (n ¼ 19), lack of data
regarding follow-up or a performed procedure (n ¼ 18),
and a bypass implanted for a popliteal aneurysm (n ¼ 19).
Therefore, 43 primary infrainguinal bypasses in 43 patients
remained for the present analysis. Patient characteristics are
listed in Table I, and bypass characteristics are listed in
Table II. Mean follow-up was 17 months (range,
0-57 months). No patients were lost to follow-up. Four
patients died of unrelated causes during follow-up.
Procedures. A total of 48 PTA procedures (two with
stent placement, one proximal and one distal) were
Table II. Bypass characteristics
Variable
No. (%)
(N ¼ 43)
Material
Vein 31 (72)
Prosthetic 11 (26)
Missing 1 (2)
Location
Proximal anastomosis
Femoral 40 (93)
Popliteal 3 (7)
Distal anastomosis
Supragenicular 19 (44)
Infragenicular 24 (56)
Table III. Treatment and lesion characteristics
Variable
No. (%)
(N ¼ 48)
Successful 46 (96)
Complications 2 (4)
Location
Proximal 13 (27)
Distal 25 (52)
Both 5 (21)
Early treatment #6 months 19 (40)
Presentation
Asymptomatic 10 (21)
Symptomatic 32 (66)
Missing 6 (13)
Concomitant treated lesions
Inﬂow 6 (13)
Outﬂow 2 (4)
In-graft stenosis 1 (2)
Outcomes after PTA
Subsequent intervention(s) 10 (21)
Occlusion 6 (13)
PTA, Percutaneous transluminal angioplasty.
Fig 1. Primary patency rates.
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The technical success rate was 96%. In the two failed pro-
cedures, surgical treatment was performed 2 days after the
procedure at the proximal and distal anastomosis of the
same bypass. One hematoma and one superﬁcial groin
infection occurred after treatment. Treatment and lesion
characteristics are listed in Table III.
Of the 43 bypasses, 28 remained fully patent and free
of restenosis until the end of follow-up, without reinterven-
tion. Subsequent intervention for restenosis was needed af-
ter 10 interventions in 10 bypasses, for which eight
subsequent PTA procedures and two surgical revisions
were performed at a mean interval of 16 months (range,
0-57 months). All subsequent procedures were successful.
One patient needed a repeat PTA procedure, which was
performed successfully at 14 months.
Occlusion occurred after six interventions in ﬁve by-
passes (one bypass was unsuccessfully treated at both the
proximal and distal anastomosis). Three of these ﬁve
remained occluded. Unsuccessful thrombolytic therapy,without further treatment, was performed in one patient;
one new bypass was directly implanted but occluded after
13 months, and eventually, amputation was necessary;
and one patient underwent no further treatment. Two
occlusions were successfully treated with surgical interven-
tion. One revision was performed after obstruction
removal, and no subsequent intervention was required.
In the bypass with the unsuccessful PTA procedure at
both the anastomoses, occlusion occurred directly after
PTA, for which direct surgical revision after obstruction
removal was performed. A new bypass was implanted
3 months later due to reocclusion.
Study end points. Primary, assisted primary, and sec-
ondary patency rates were 90%, 93%, and 93% at 6 months;
80%, 88%, and 88% at 12 months; and 58%, 85%, and 88%
at 24 months, respectively (Figs 1-3). No signiﬁcant dif-
ferences in primary, assisted primary, and secondary
patency rates were determined between treated anasto-
moses that were proximal (log-rank ¼ 0.35, P ¼ .55),
distal (log-rank ¼ 0.55, P ¼ .76), or both (log-rank ¼
0.98, P ¼ .62).
Primary patency rate for prosthetic bypasses (n ¼ 8)
was 67% compared with 84% for autologous vein bypasses
(n ¼ 20) at 1 year of follow-up (log-rank ¼ 1.33, P ¼ .25).
In case of early (#6 months from implantation) endovascu-
lar intervention (n ¼ 14), primary patency rate was 67% vs
90% compared with later (n ¼ 15) treatments (log-rank ¼
1.40, P ¼ .24). Bypasses with a supragenicular (n ¼ 13)
anastomosis had primary patency rates of 88% at 12 months
compared with 74% for infragenicular (n ¼ 16) anasto-
mosis (log-rank ¼ 1.31, P ¼ .25).
Fig 3. Secondary patency rates.
Fig 2. Assisted primary patency rates.
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differ between prosthetic (n ¼ 7) and venous (n ¼ 19) by-
passes and an early (n ¼ 12) vs a late (n ¼ 15) ﬁrst inter-
vention. Regarding the level of distal anastomosis,
bypasses with a supragenicular anastomosis (n ¼ 12) had
assisted primary patency rates of 91% at 1 year of follow-
up compared with 85% for infragenicular anastomosis
(n ¼ 15; log-rank ¼ 0.16, P ¼ .61).
Intervention for restenosis in bypasses with infragenic-
ular distal anastomosis (n ¼ 15) had secondary patency rate
of 84% at 1 year of follow-up vs 92% patency in bypasses
with the distal anastomosis located above the knee (n ¼
12; log-rank ¼ 1.02; P ¼ .31). Secondary patency rates
did not signiﬁcantly differ between graft type used (19
vein and 7 prosthetic) and early (n ¼ 12) vs late (n ¼
15) ﬁrst treatments (Table IV).
DISCUSSION
Anastomotic stenoses are the most common cause of
patency loss in infrainguinal bypasses.6 Despite this, the
outcome of treatment of those speciﬁc lesions has had little
attention in previous reports. There is a paucity of data
regarding treatment of anastomotic stenoses in infraingui-
nal BARs. The few existing studies, however, mix in-graft
with anastomotic stenoses, and the results are equivocal;
furthermore, follow-up duration is generally limited.
Therefore, no clear and focused data exist on the patency
rates after treatment of purely anastomotic stenoses. In
our series focusing on endovascular treatment of anasto-
motic stenoses, the mean follow-up was 17 months (range,0-57 months), and no patients were lost to follow-up. Pri-
mary, assisted primary, and secondary patency rates were
58%, 85%, and 88% at 2 years of follow-up, respectively.
Overall assisted primary patency rates of up to 65% at
5 years after PTA for in-graft stenoses have been previously
described.6 For PTA of distal anastomosis alone, overall
primary rates of 32% and assisted primary patency rates of
53% have been reported after 3 years.12 However, in
contrast to our study, occluded bypasses undergoing
thrombolysis before PTA were also included. Furthermore,
treatment of multilevel stenoses has been shown to inﬂu-
ence the assisted primary patency rate. Studies that
included only vein grafts did not ﬁnd any association be-
tween location of the stenosis (in-graft or anastomotic)
and outcomes after PTA in vein grafts.13,14 Cumulative
2-year patency rates after PTA for short severe anastomotic
lesions (proximal and distal) in 39 bypasses (35 venous and
four prosthetic) have been described as signiﬁcantly worse
(45%) than comparable in-graft stenoses (86%).15 Also, the
use of prosthetic bypasses has been described as a poor
prognostic factor, and worse outcomes compared with
vein bypasses have been reported for endovascular in-
graft and anastomotic interventions.1,16
The only prior study speciﬁcally reviewing the outcome
of treatment for stenosis at the anastomotic site of infrain-
guinal bypasses comprised endovascular or surgical treat-
ment of 39 bypasses in 36 patients.7 Assisted primary and
secondary patency rates of 42% and 60%, respectively, at
2 years of follow-up were reported; overall for PTA (n ¼
26) and surgical (n ¼ 13) treatment, patency rates were not
affected by type of treatment. In contrast to our study, by-
passes implanted for popliteal aneurysms and treatments of
Table IV. Prognostic factors at 1 yeara
Variable BAR, No.
Primary
patency, % P BAR, No.
Assisted primary
patency, % P BAR, No.
Secondary
patency, % P
Material
Vein 20 84 .25b 19 87 .47b 19 85 .99
Prosthetic 8 67 7 91 7 88
Distal anastomosis
Supragenicular 13 88 .25b 12 91 .61 12 92 .31
Infragenicular 16 74 15 85 15 84
Time
#6 months 14 67 .24b 12 86 .98 12 86 .65b
>6 months 15 90 15 88 15 89
BAR, Bypass at risk.
aThis subanalysis should be interpreted with care due to the small numbers in the subgroups.
bStandard error >10% in ﬁve of nine procedures.
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were included. As stated in that study, the outcomes after
intervention for durable bypass patency may be signiﬁcantly
improved if the lesions are treated before occlusion occurs.
Our study is unique in selectively analyzing treatment of anas-
tomotic stenoses found by graft surveillance instead of occlu-
sion of the bypass and, probably hence, reports more
favorable patency rates for PTA of these stenoses.
The optimal treatment approach for anastomotic steno-
ses in infrainguinal bypasses, especially with asymptomatic
presentation, remains undecided. Of relevance, PTA in
distal anastomotic lesions does not compromise a future op-
portunity to repeat endovascular or surgical treatment.12,13
What remains a problem after PTA of in-graft stenosis is the
relatively high need for subsequent interventions (target
lesion revascularization) due to restenosis or occlusion,17
especially in case of perianastomotic lesions.7,15,16 For this
reason, some authors have stated that surgical repair of
anastomotic lesions should be the treatment of ﬁrst choice
and that PTA should be reserved for patients not suitable
for surgical treatment.14,18 Our data conﬁrm the need for
subsequent intervention after PTA in some patients. How-
ever, most importantly, 28 of the 43 bypasses remained
fully patent and free of restenosis until the end of follow-
up, without the need for further reintervention.
The increasing number of events with time limits the
durability of endovascular treatment for BARs. To reliably
interpret the position of endovascular vs open surgical
intervention, we need better data on the longer-term out-
comes of surgical intervention for BARs. In the meantime,
because PTA does not compromise the opportunity for
subsequent open or endovascular intervention and has
high success rates and acceptable patency rates after treat-
ment, we consider PTA the treatment of ﬁrst choice in
case of anastomotic stenoses in a BAR needing interven-
tion. However, this statement should be interpreted with
care due to the relatively short follow-up duration in
most of the patients included and should therefore be
conﬁrmed in future cohort studies.
Also in our study, all patients were suitable for PTA
after patients who required thrombolysis were excludedfrom the analysis. Because this observation may be inﬂu-
enced by chance, we cannot at this stage conclude that
patients undergoing thrombolysis are not suitable for
PTA treatment of an anastomosis.
Owing to strict follow-up criteria, a decline in available
grafts was seen during follow-up. In contrast to several
previous studies, follow-up started at the moment of the
intervention and not when the bypass was implanted. Also,
follow-up ended at the last check on patency of the bypass
and not at themoment of reporting results. The last checkup
for several patients for reporting results was >6 months
ago; therefore, follow-up for these patients appears to be
shorter than might be expected. Besides six patients who
underwent their last patency check up >6 months ago and
four patients who reached the study end point, four patients
died shortly after the intervention. This leaves 29 of 43 grafts
for analysis at 6 months of follow-up.
As stated before, the strength of our analysis is that this
cohort consists of a very selective group of infrainguinal by-
passes with anastomotic stenoses with no previous in-graft
interventions and occlusions. Therefore, conclusions of this
study will be clinically applicable to a selected number of
patients. Also, the retrospective character of this study and
the limited number of patients, especially in the subgroup
analyses, are a drawback on the strengths of its conclusions.
To design the optimal treatment strategy for anastomotic
lesions in infrainguinal BARs, larger prospective studies
with longer follow-up also analyzing treatment after throm-
bolytic therapy for occlusion and failed PTA are needed.
Advances in endovascular revascularization techniques
have shown promising results with possible applicability
in BARs with anastomotic lesions. Several prospective trials
showed a signiﬁcant reduction in late lumen loss and target
lesion revascularization in femoropopliteal arterial stenosis
using drug-eluting balloons.19,20 A pilot study of the use
of cutting balloon angioplasty (CBA) showed good results
in BARs.21 A later study performed at the same institution
showed comparable outcomes (treatment failure) after sur-
gery and CBA and inferior results for conventional PTA.22
Anastomotic lesions in infrainguinal bypasses treated by
CBA were evaluated separately in pilot studies, and results
JOURNAL OF VASCULAR SURGERY
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advances in technology, further improving especially the
longer-term outcome of an endovascular approach of
BARs.
CONCLUSIONS
For infrainguinal BARs for occlusion due to anasto-
motic stenoses, PTA has a high success rate and acceptable
durability. PTA may be considered as a safe ﬁrst-line treat-
ment when reintervention is considered. Although subse-
quent interventions may be required in selected patients,
patency rates over time are still considered good.
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